Spirair, Inc.
PrivateLast Round
Series B
Mar 10, 2026
Total Funding Raised
$12.8M
Momentum Score
25 /100
Company Overview
Spirair, Inc. is a medical device company developing minimally invasive solutions for otolaryngologists to improve patient care for nasal obstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spirair, Inc. Comps
Public and private peers based on sector, stage, and business model.
Spirair, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 10, 2026 | ||||
| Series B | Aug 12, 2025 |
Key People
Founding team and executive leadership
Spirair, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cadence Healthcare Ventures | Series B |
| View Ventures | Series A, Series B |
| 1809 Capital | Series B |
| Sonder Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$25M round completed.
Spirair, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spirair, Inc.'s valuation, stock price, and market status.
